Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation

Biodegradation

Volumn 21, Issue 5, 2010, Pages 681-689

  Hata, Takayuki ^a   Kawai, Shingo ^a   Okamura, Hideo ^b   Nishida, Tomoaki ^a  

^a SHIZUOKA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Cytochrome P450; Diclofenac; Hydroxylation; Mefenamic acid; White rot fungus

Indexed keywords

CYTOCHROME P450; DICLOFENAC; MEFENAMIC ACID; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHANEROCHAETE SORDIDA; THAMNOCEPHALUS PLATYURUS; WHITE ROT FUNGI;

DETOXIFICATION; HYDROXYLATION; METABOLISM; METABOLITES; METHANOL; RESONANCE;

ACIDS;

1 AMINOBENZOTRIAZOLE; 1-AMINOBENZOTRIAZOLE; CYTOCHROME P450; DICLOFENAC; ENZYME INHIBITOR; MEFENAMIC ACID; TRIAZOLE DERIVATIVE;

CRUSTACEAN; CYTOCHROME; DETOXIFICATION; DISEASE TREATMENT; DRUG; FRESHWATER ENVIRONMENT; FUNGAL DISEASE; IDENTIFICATION METHOD; INHIBITOR; MASS SPECTROMETRY; METABOLITE; NUCLEAR MAGNETIC RESONANCE; ORGANIC ACID; REMOVAL EXPERIMENT; TOXICITY;

ARTICLE; BIOREMEDIATION; BIOTRANSFORMATION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; PHANEROCHAETE;

BIODEGRADATION, ENVIRONMENTAL; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DICLOFENAC; ENZYME INHIBITORS; MEFENAMIC ACID; PHANEROCHAETE; TRIAZOLES;

CRUSTACEA; FUNGI; PHANEROCHAETE; PHANEROCHAETE SORDIDA; THAMNOCEPHALUS PLATYURUS;

EID: 77955272834     PISSN: 09239820     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10532-010-9334-3     Document Type: Article

References (40)

1. Asgher M, Bhatti HN, Ashraf M, Legge RL (2008) Recent developments in biodegradation of industrial pollutants by white rot fungi and their enzyme system. Biodegradation 19: 771-783.
2. Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333: 167-184.
3. Blum W, Faigle JW, Pfaar U, Sallmann AR (1996) Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemicalionization mass spectrometry. J Chromatogr B 685: 251-263.
4. Bort R, Macé K, Boobis A, Gómez-Lechón MJ, Pfeifer A, Castell J (1999) Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol 58: 787-796.
5. Cambria MT, Minniti Z, Librando V, Cambria A (2008) Degradation of polycyclic aromatic hydrocarbons by Rigidoporus lignosus and its laccase in the presence of redox mediators. Appl Biochem Biotechnol 149: 1-8.
6. Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38: 2918-2926.
7. Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39: 4797-4807.
8. Ehlers GA, Rose PD (2005) Immobilized white-rot fungal biodegradation of phenol and chlorinated phenol in trickling packed-bed reactors by employing sequencing batch operation. Biores Technol 96: 1264-1275.
9. Glazko AJ (1966) Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition. Ann Phys Med Suppl: 23-36.
10. González S, Müller J, Petrovic M, Barceló D, Knepper TP (2006) Biodegradation studies of selected priority acidic pesticides and diclofenac in different bioreactors. Environ Pollut 144: 926-932.
11. Gröning J, Held C, Garten C, Claußnitzer U, Kaschabek SR, Schlömann M (2007) Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere 69: 509-516.
12. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131: 5-17.
13. Jones OAH, Voulvoulis N, Lester JN (2007) The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environ Pollut 145: 738-744.
14. Kamei I, Suhara H, Kondo R (2005) Phylogenetical approach to isolation of white-rot fungi capable of degrading polychlorinated dibenzo-p-dioxin. Appl Microbiol Biotechnol 69: 358-366.
15. Kretz-Rommel A, Boelsterli UA (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol Appl Pharmacol 120: 155-161.
16. Marco-Urrea E, Pérez-Trujillo M, Vicent T, Caminal G (2009a) Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products by Trametes versicolor. Chemosphere 74: 765-772.
17. Marco-Urrea E, Pérez-Trujillo M, Cruz-Morató C, Caminal G, Vicent T (2009b) White-rot fungus-mediated degradation of the analgesic ketoprofen and identification of intermediates by HPLC-DAD-MS and NMR. Chemosphere. doi: 10. 1016/j. chemosphere. 2009. 10. 009.
18. Marco-Urrea E, Radjenović J, Caminal G, Petrović M, Vicent T, Barceló D (2009c) Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor. Water Res. doi: 10. 1016/j. watres. 2009. 09. 049.
19. Martínez AT, Speranza M, Ruiz-Dueñas FJ, Ferreira P, Camarero S, Guillén F, Martínez MJ, Gutiérrez A, del Río JC (2005) Biodegradation of lignocellulosics: microbial, chemical, and enzymatic aspects of the fungal attack of lignin. Int Microbiol 8: 195-204.
20. Matsuzaki F, Wariishi H (2004) Functional diversity of cytochrome P450 s of the white-rot fungus Phanerochaete chrysosporium. Biochem Biophys Res Commun 324: 387-393.
21. Mizuno H, Hirai H, Kawai S, Nishida T (2009) Removal of estrogenic activity of iso-butylparaben and n-butylparaben by laccase in the presence of 1-hydroxybenzotriazole. Biodegradation 20: 533-539.
22. Quintana JB, Weiss S, Reemtsma T (2005) Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39: 2654-2664.
23. Rodríguez I, Quintana JB, Carpinteiro J, Carro AM, Lorenzo RA, Cela R (2003) Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tert.-butyldimethylsilyl derivatives. J Chromatogr A 985: 265-274.
24. Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33: 596-601.
25. Sato J, Yamane Y, Ito K, Bando H (1993) Structures of mefenamic acid metabolites from human urine. Biol Pharm Bull 16: 811-812.
26. Shen S, Marchick MR, Davis MR, Doss GA, Pohl LR (1999) Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac. Chem Res Toxicol 12: 214-222.
27. Stierlin H, Faigle JW (1979) Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 9: 611-621.
28. Stuer-Lauridsen F, Birkved M, Hansen LP, Lützhøft HC, Halling-Sørensen B (2000) Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40: 783-789.
29. Suzuki K, Hirai H, Murata H, Nishida T (2003) Removal of estrogenic activities of 17β-estradiol and ethinylestradiol by ligninolytic enzymes from white rot fungi. Water Res 37: 1972-1975.
30. Tamagawa Y, Hirai H, Kawai S, Nishida T (2005) Removal of estrogenic activity of endocrine-disrupting genistein by ligninolytic enzymes from white rot fungi. FEMS Microbiol Lett 244: 93-98.
31. Tamagawa Y, Hirai H, Kawai S, Nishida T (2007) Removal of estrogenic activity of 4-tert-octylphenol by ligninolytic enzymes from white rot fungi. Environ Toxicol 22: 281-286.
32. Tang W, Stearns RA, Wang RW, Chiu SH, Baillie TA (1999) Roles of human hepatic cytochrome P450 s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem Res Toxicol 12: 192-199.
33. Tauxe-Wuersch A, De Alencastro LF, Grandjean D, Tarradellas J (2005) Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 39: 1761-1772.
34. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32: 3245-3260.
35. Tien M, Kirk TK (1988) Lignin peroxidase of Phanerochaete chrysosporium. Methods Enzymol 161: 238-249.
36. Tixier C, Singer HP, Oellers S, Müller SR (2003) Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 37: 1061-1068.
37. Tsutsumi Y, Haneda T, Nishida T (2001) Removal of estrogenic activities of bisphenol A and nonylphenol by oxidative enzymes from lignin-degrading basidiomycetes. Chemosphere 42: 271-276.
38. Webster R, Pacey M, Winchester T, Johnson P, Jezequel S (1998) Microbial oxidative metabolism of diclofenac: production of 4′-hydroxydiclofenac using Epiccocum nigrum IMI354292. Appl Microbiol Biotechnol 49: 371-376.
39. Weigel S, Aulinger A, Brockmeyer R, Harms H, Löffler J, Reincke H, Schmidt R, Stachel B, von Tümpling W, Wanke A (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57: 107-126.
40. Zwiener C, Frimmel FH (2003) Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 309: 201-211.